99 related articles for article (PubMed ID: 26280599)
1. Speciation of the Potential Antitumor Agent Vanadocene Dichloride in the Blood Plasma and Model Systems.
Sanna D; Ugone V; Micera G; Pivetta T; Valletta E; Garribba E
Inorg Chem; 2015 Sep; 54(17):8237-50. PubMed ID: 26280599
[TBL] [Abstract][Full Text] [Related]
2. Biorelevant reactions of the potential anti-tumor agent vanadocene dichloride.
Sanna D; Serra M; Ugone V; Manca L; Pirastru M; Buglyó P; Bíró L; Micera G; Garribba E
Metallomics; 2016 May; 8(5):532-41. PubMed ID: 27121101
[TBL] [Abstract][Full Text] [Related]
3. Investigation of vanadocene(IV) alpha-amino acid complexes: synthesis, structure, and behavior in physiological solutions, human plasma, and blood.
Vinklárek J; Palácková H; Honzícek J; Holubová J; Holcapek M; Císarová I
Inorg Chem; 2006 Mar; 45(5):2156-62. PubMed ID: 16499378
[TBL] [Abstract][Full Text] [Related]
4. Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug.
Sanna D; Ugone V; Micera G; Buglyó P; Bíró L; Garribba E
Dalton Trans; 2017 Jul; 46(28):8950-8967. PubMed ID: 28640312
[TBL] [Abstract][Full Text] [Related]
5. On the transport of vanadium in blood serum.
Sanna D; Micera G; Garribba E
Inorg Chem; 2009 Jul; 48(13):5747-57. PubMed ID: 19514735
[TBL] [Abstract][Full Text] [Related]
6. Binding of V(IV) to human transferrin: potential relevance to anticancer activity of vanadocene dichloride.
Du H; Xiang J; Zhang Y; Tang Y; Xu G
J Inorg Biochem; 2008 Jan; 102(1):146-9. PubMed ID: 17825420
[TBL] [Abstract][Full Text] [Related]
7. An experimental and theoretical study of the Cp2VO2CO: use of 13CO3(2-) for structure investigation of d1-metallocene complexes.
Vinklárek J; Honzícek J; Holubová J
Magn Reson Chem; 2004 Oct; 42(10):870-4. PubMed ID: 15366060
[TBL] [Abstract][Full Text] [Related]
8. Characterization and biotransformation in the plasma and red blood cells of V(IV)O(2+) complexes formed by ceftriaxone.
Sanna D; Fabbri D; Serra M; Buglyó P; Bíró L; Ugone V; Micera G; Garribba E
J Inorg Biochem; 2015 Jun; 147():71-84. PubMed ID: 25601642
[TBL] [Abstract][Full Text] [Related]
9. Speciation of potential anti-diabetic vanadium complexes in real serum samples.
Sanna D; Ugone V; Serra M; Garribba E
J Inorg Biochem; 2017 Aug; 173():52-65. PubMed ID: 28499214
[TBL] [Abstract][Full Text] [Related]
10. Vanadocene dichloride inhibits cell proliferation by targeting Aurora B.
Ting TC; Chang MY; Hsu TY; Wang WP; Hsieh YJ; Chang CJ
Metallomics; 2018 Aug; 10(8):1099-1106. PubMed ID: 30027187
[TBL] [Abstract][Full Text] [Related]
11. VO2+ complexation by bioligands showing keto-enol tautomerism: a potentiometric, spectroscopic, and computational study.
Sanna D; Varnágy K; Timári S; Micera G; Garribba E
Inorg Chem; 2011 Oct; 50(20):10328-41. PubMed ID: 21902189
[TBL] [Abstract][Full Text] [Related]
12. Constructing transferrin receptor targeted drug delivery system by using doxorubicin hydrochloride and vanadocene dichloride.
Zhang Y; Xiang J; Liu Y; Zhang X; Tang Y
Bioorg Med Chem Lett; 2011 Oct; 21(19):5982-6. PubMed ID: 21862329
[TBL] [Abstract][Full Text] [Related]
13. Behavior of the potential antitumor V(IV)O complexes formed by flavonoid ligands. 1. Coordination modes and geometry in solution and at the physiological pH.
Sanna D; Ugone V; Lubinu G; Micera G; Garribba E
J Inorg Biochem; 2014 Nov; 140():173-84. PubMed ID: 25127230
[TBL] [Abstract][Full Text] [Related]
14. Carbonate adsorption on goethite in competition with phosphate.
Rahnemaie R; Hiemstra T; van Riemsdijk WH
J Colloid Interface Sci; 2007 Nov; 315(2):415-25. PubMed ID: 17825833
[TBL] [Abstract][Full Text] [Related]
15. Interaction of antidiabetic vanadium compounds with hemoglobin and red blood cells and their distribution between plasma and erythrocytes.
Sanna D; Serra M; Micera G; Garribba E
Inorg Chem; 2014 Feb; 53(3):1449-64. PubMed ID: 24437949
[TBL] [Abstract][Full Text] [Related]
16. New developments in the comprehension of the biotransformation and transport of insulin-enhancing vanadium compounds in the blood serum.
Sanna D; Micera G; Garribba E
Inorg Chem; 2010 Jan; 49(1):174-87. PubMed ID: 19947643
[TBL] [Abstract][Full Text] [Related]
17. Complex formation in aqueous solution and in the solid state of the potent insulin-enhancing V(IV)O2+ compounds formed by picolinate and quinolinate derivatives.
Lodyga-Chruscinska E; Micera G; Garribba E
Inorg Chem; 2011 Feb; 50(3):883-99. PubMed ID: 21226475
[TBL] [Abstract][Full Text] [Related]
18. Tumor inhibition by metallocenes: ultrastructural localization of titanium and vanadium in treated tumor cells by electron energy loss spectroscopy.
Köpf-Maier P; Krahl D
Chem Biol Interact; 1983 Jun; 44(3):317-28. PubMed ID: 6872095
[TBL] [Abstract][Full Text] [Related]
19. Differences in vanadocene dichloride and cisplatin effect on MOLT-4 leukemia and human peripheral blood mononuclear cells.
Havelek R; Siman P; Cmielova J; Stoklasova A; Vavrova J; Vinklarek J; Knizek J; Rezacova M
Med Chem; 2012 Jul; 8(4):615-21. PubMed ID: 22530915
[TBL] [Abstract][Full Text] [Related]
20. A novel V(IV)O-pyrimidinone complex: synthesis, solution speciation and human serum protein binding.
Gonçalves G; Tomaz I; Correia I; Veiros LF; Castro MM; Avecilla F; Palacio L; Maestro M; Kiss T; Jakusch T; Garcia MH; Pessoa JC
Dalton Trans; 2013 Sep; 42(33):11841-61. PubMed ID: 23677414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
